On May 19, we recognize World Inflammatory Bowel Disease (IBD) Day at Janssen by shedding light on the more than five million people around the world affected by Crohn’s disease and ulcerative colitis (UC).
At Janssen, we are focused on learning more about the immune system to improve the lives of those living with debilitating immune diseases like IBD. Our scientists collaborate with researchers, healthcare providers, academic and patient organizations around the world to advance the science and develop innovative treatments to promote health and prevent, intercept and cure diseases. That’s why this year, Janssen and Johnson & Johnson Innovation, JLABS are seeking external innovators to submit their ideas for the IBD Stress Test QuickFire Challenge to evaluate immune and gastrointestinal health and ultimately predict risk of IBD. Submit your application today!
Additionally, in honor of World IBD Day, mark your calendar for the #TalkIBD Twitter Chat hosted by @JanssenEMEA and @TalkHealth on May 18 at 8:00 a.m. ET. You can also showcase your support on May 19 by posting on social media using #WorldIBDDay as we stand united with all of those impacted by IBD.
